Better Health for All

Avita Medical's core products, RECELL, PermeaDerm, and Cohealyx, are entirely focused on wound care and skin restoration, delivering significant health benefits. RECELL has been shown to reduce donor skin requirements by 27% to 97.5% and resulted in less pain, faster healing, and improved patient satisfaction.

PermeaDerm facilitated successful healing with minimal scarring and preserved joint mobility in pediatric patients, while Cohealyx facilitated wound bed vascularization within 5-10 days. The company has no products with negative health impacts, and its primary product, Recell, received FDA approval in September 2018, indicating over 5 years without harmful products. Recell's safety record is outstanding, with no device-related serious adverse events recorded. The use of RECELL has been associated with substantial cost savings per patient, ranging from an average of $22,268 for small burns to $36,949 for burns up to 50% TBSA, and projected annual savings of $5.3 to $6.8 million for a representative U.S. burn center. The company extended its product label to include pediatric use in June 2021. Avita Medical invests approximately $5 million each quarter in R&D. The company maintains a compliance hotline, a non-retaliation policy, and adheres to the AdvaMed Code of Ethics, ensuring transparency and ethical conduct. Avita Care Solutions (a subsidiary) focuses on PrEP for HIV prevention, with PrEP potentially reducing HIV risk by 99% with correct use. Avita Medical complies with all Federal and State reporting requirements concerning payments to healthcare professionals and ensures the privacy of information consistent with applicable law and regulations.

Fair Money & Economic Opportunity

Avita Medical, Inc. is a regenerative medicine company focused on medical devices for wound care.

The provided articles do not contain evidence of the company engaging in activities related to lending, insuring, moving, or storing money for consumers. Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives (financial), data accessibility (financial), fair lending compliance, wealth building outcome, profit reinvestment (community finance), financial literacy initiatives, debt burden ratio, geographic inclusion (banking deserts), and product simplicity (financial products), are not applicable to its core business. Consequently, all KPIs are scored as 0, as per the rubric's 'Not applicable' tier.

Honest & Fair Business

The provided articles do not contain any specific quantitative data or concrete qualitative facts relevant to the 'Honest & Fair Business' ethical value.

There is no information regarding regulatory fines, transparency index scores, details of a whistleblower policy, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policy specifics, or third-party verification of ethical claims. Therefore, no KPIs can be scored based on the evidence provided.

Kind to Animals

The company's products are animal-derived, with the RECELL® Enzyme explicitly stated as animal-derived.

There is no evidence that any of the company's products are certified cruelty-free. Furthermore, there is no evidence of any animal-derived ingredients or materials being replaced with ethical alternatives.

Zero Waste & Sustainable Products

Avita Medical, Inc. has not reported any specific data regarding its waste management, recycling, or sustainable product initiatives.

There is no information available on waste diversion rates, product recyclability, packaging sustainability, or the use of recycled content in its products. The company has not disclosed any efforts to reduce single-use plastics, implement take-back programs, or integrate circular design principles. Furthermore, there is no data on waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, or zero-waste certifications. No waste disposal violations or citations are reported. Information on material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education programs is also absent.